| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is experiencing significant advancements in Product/Service Development, particularly in oncology, which is bolstered by a strong product pipeline. The company's commitment to innovative cancer therapies showcases its potential for growth and instills investor confidence, as evidenced by a robust stock performance. However, challenges remain in navigating regulatory hurdles and competition in a rapidly evolving pharmaceutical landscape. Overall, the optimistic outlook on Eli Lilly's growth opportunities underscores its position in the industry. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.6 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.8, and the negative at -0.2 on 2025-10-15. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (4.6) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-15 | 0%(0%) | 0 | 0% | 0.6 | 4.6 | -1 | |||||||
| 2025-10-14 | 0%(0%) | 0 | 0% | 0.6 | 4.6 | -1 | |||||||
| 2025-10-13 | 0%(0%) | 0 | 0% | 0.6 | 4.7 | -1 | |||||||
| 2025-10-12 | 0%(0%) | 0 | 0% | 0.6 | 4.5 | -1 | |||||||
| 2025-10-11 | 0%(0%) | 0 | 0% | 0.6 | 4.5 | -1 | |||||||
| 2025-10-10 | 0%(0%) | 0 | 0% | 0.6 | 4.4 | -1 | |||||||
| 2025-10-09 | 0%(0%) | 0 | 0% | 0.5 | 4.1 | -1 | |||||||
| 2025-10-08 | 0%(0%) | 0 | 0% | 0.5 | 4.2 | -1 | |||||||
| 2025-10-07 | 0%(0%) | 0 | 0% | 0.5 | 4 | -1 | |||||||
| 2025-10-06 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-10-15 17:01:58 Eli Lilly has experienced growth interspersed with volatility, indicating a dynamic market environment in which the company operates, particularly noted in its stock fluctuations. |
| 2025-10-15 17:01:58 As the largest healthcare company by market cap, Eli Lilly showcases significant competitive advantages that contribute to its strong market presence and performance. |
| 2025-10-15 17:01:58 Despite facing increased competition in the diabetes and obesity treatment markets, Eli Lilly has maintained resilience, demonstrating its strong positioning in these industries. |
| 2025-10-15 17:01:58 The company has returned significant value to shareholders through dividends and buybacks, amounting to $47 billion, reflecting a strong shareholder-centric strategy. |
| 2025-10-15 17:01:58 Eli Lilly has shown remarkable stock performance, being one of the best-performing stocks in the healthcare sector over the past decade, with strong returns and shareholder benefits. |